38 related articles for article (PubMed ID: 1672835)
1. Host polymorphisms and COVID-19 infection.
Delanghe JR; Speeckaert MM
Adv Clin Chem; 2022; 107():41-77. PubMed ID: 35337605
[TBL] [Abstract][Full Text] [Related]
2. Emerging Role of Dipeptidyl Peptidase-4 in Autoimmune Disease.
Huang J; Liu X; Wei Y; Li X; Gao S; Dong L; Rao X; Zhong J
Front Immunol; 2022; 13():830863. PubMed ID: 35309368
[TBL] [Abstract][Full Text] [Related]
3. Spared Nerve Injury Causes Sexually Dimorphic Mechanical Allodynia and Differential Gene Expression in Spinal Cords and Dorsal Root Ganglia in Rats.
Ahlström FHG; Mätlik K; Viisanen H; Blomqvist KJ; Liu X; Lilius TO; Sidorova Y; Kalso EA; Rauhala PV
Mol Neurobiol; 2021 Oct; 58(10):5396-5419. PubMed ID: 34331199
[TBL] [Abstract][Full Text] [Related]
4. Dipeptidylpeptidase-4 levels and DPP4 gene polymorphisms in patients with COVID-19. Association with disease and with severity.
Posadas-Sánchez R; Sánchez-Muñoz F; Guzmán-Martín CA; Hernández-Díaz Couder A; Rojas-Velasco G; Fragoso JM; Vargas-Alarcón G
Life Sci; 2021 Jul; 276():119410. PubMed ID: 33774023
[TBL] [Abstract][Full Text] [Related]
5. DPP-4 Inhibitors as Potential Candidates for Antihypertensive Therapy: Improving Vascular Inflammation and Assisting the Action of Traditional Antihypertensive Drugs.
Zhang J; Chen Q; Zhong J; Liu C; Zheng B; Gong Q
Front Immunol; 2019; 10():1050. PubMed ID: 31134095
[TBL] [Abstract][Full Text] [Related]
6. Glial cell type-specific changes in spinal dipeptidyl peptidase 4 expression and effects of its inhibitors in inflammatory and neuropatic pain.
Király K; Kozsurek M; Lukácsi E; Barta B; Alpár A; Balázsa T; Fekete C; Szabon J; Helyes Z; Bölcskei K; Tékus V; Tóth ZE; Pap K; Gerber G; Puskár Z
Sci Rep; 2018 Feb; 8(1):3490. PubMed ID: 29472575
[TBL] [Abstract][Full Text] [Related]
7. DPP4 Inhibitors Can Be a Drug of Choice for Type 3 Diabetes: A Mini Review.
Chalichem NSS; Gonugunta C; Krishnamurthy PT; Duraiswamy B
Am J Alzheimers Dis Other Demen; 2017 Nov; 32(7):444-451. PubMed ID: 28747063
[TBL] [Abstract][Full Text] [Related]
8. Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.
Klemann C; Wagner L; Stephan M; von Hörsten S
Clin Exp Immunol; 2016 Jul; 185(1):1-21. PubMed ID: 26919392
[TBL] [Abstract][Full Text] [Related]
9. A potential role for dendritic cell/macrophage-expressing DPP4 in obesity-induced visceral inflammation.
Zhong J; Rao X; Deiuliis J; Braunstein Z; Narula V; Hazey J; Mikami D; Needleman B; Satoskar AR; Rajagopalan S
Diabetes; 2013 Jan; 62(1):149-57. PubMed ID: 22936179
[TBL] [Abstract][Full Text] [Related]
10. The in vivo expression of dipeptidyl peptidases 8 and 9.
Yu DM; Ajami K; Gall MG; Park J; Lee CS; Evans KA; McLaughlin EA; Pitman MR; Abbott CA; McCaughan GW; Gorrell MD
J Histochem Cytochem; 2009 Nov; 57(11):1025-40. PubMed ID: 19581630
[TBL] [Abstract][Full Text] [Related]
11. CD26/dipeptidyl peptidase 4-deficiency alters thymic emigration patterns and leukcocyte subsets in F344-rats age-dependently.
Klemann C; Schade J; Pabst R; Leitner S; Stiller J; von Hörsten S; Stephan M
Clin Exp Immunol; 2009 Feb; 155(2):357-65. PubMed ID: 19055685
[TBL] [Abstract][Full Text] [Related]
12. Clinical and oncologic implications in epigenetic down-regulation of CD26/dipeptidyl peptidase IV in adult T-cell leukemia cells.
Tsuji T; Sugahara K; Tsuruda K; Uemura A; Harasawa H; Hasegawa H; Hamaguchi Y; Tomonaga M; Yamada Y; Kamihira S
Int J Hematol; 2004 Oct; 80(3):254-60. PubMed ID: 15540901
[TBL] [Abstract][Full Text] [Related]
13. Peptidases in human bronchoalveolar lining fluid, macrophages, and epithelial cells: dipeptidyl (amino)peptidase IV, aminopeptidase N, and dipeptidyl (carboxy)peptidase (angiotensin-converting enzyme).
Juillerat-Jeanneret L; Aubert JD; Leuenberger P
J Lab Clin Med; 1997 Dec; 130(6):603-14. PubMed ID: 9422334
[TBL] [Abstract][Full Text] [Related]
14. Dipeptidyl-peptidase IV secreted by Aspergillus fumigatus, a fungus pathogenic to humans.
Beauvais A; Monod M; Wyniger J; Debeaupuis JP; Grouzmann E; Brakch N; Svab J; Hovanessian AG; Latgé JP
Infect Immun; 1997 Aug; 65(8):3042-7. PubMed ID: 9234752
[TBL] [Abstract][Full Text] [Related]
15. Genomic organization, exact localization, and tissue expression of the human CD26 (dipeptidyl peptidase IV) gene.
Abbott CA; Baker E; Sutherland GR; McCaughan GW
Immunogenetics; 1994; 40(5):331-8. PubMed ID: 7927537
[TBL] [Abstract][Full Text] [Related]
16. Dipeptidyl peptidase IV (DP IV) activity in serum and on lymphocytes of MRL/Mp-lpr/lpr mice correlates with disease onset.
Kubota T; Iizuka H; Bachovchin WW; Stollar BD
Clin Exp Immunol; 1994 May; 96(2):292-6. PubMed ID: 7910536
[TBL] [Abstract][Full Text] [Related]
17. Expression of ectopeptidases in scleroderma.
Bou-Gharios G; Osman J; Atherton A; Monoghan P; Vancheeswaran R; Black C; Olsen I
Ann Rheum Dis; 1995 Feb; 54(2):111-6. PubMed ID: 7702397
[TBL] [Abstract][Full Text] [Related]
18. Human dipeptidyl peptidase IV gene promoter: tissue-specific regulation from a TATA-less GC-rich sequence characteristic of a housekeeping gene promoter.
Böhm SK; Gum JR; Erickson RH; Hicks JW; Kim YS
Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):835-43. PubMed ID: 7487939
[TBL] [Abstract][Full Text] [Related]
19. Expression of the rat CD26 antigen (dipeptidyl peptidase IV) on subpopulations of rat lymphocytes.
Gorrell MD; Wickson J; McCaughan GW
Cell Immunol; 1991 Apr; 134(1):205-15. PubMed ID: 1672835
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
